Selected research
Industry Research
Hip and Joint Supplement for Pet Industry Research Report 2026
Market perspective
The global Hip and Joint Supplement for Pet market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Hip and Joint Supplement for Pet is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Hip and Joint Supplement for Pet is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Hip and Joint Supplement for Pet is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Hip and Joint Supplement for Pet include Mars, Nestle Purina, EverRoot, Milk-Bone, Blue Buffalo, VetIQ, JPK Nutri, maxxipaws and Unicharm, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Hip and Joint Supplement for Pet market in terms of revenue (US$ million) and, where applicable, sales volume (t), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/t) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Hip and Joint Supplement for Pet Market by Company
Mars
Nestle Purina
EverRoot
Milk-Bone
Blue Buffalo
VetIQ
JPK Nutri
maxxipaws
Unicharm
OSCAR Pet Foods
Affinity Petcare
MoonShine
Yantai China Pet Foods
GREENIES
Wagg
Petpal Tech
DogKind
Pet Treats
Pet Chews
Hip and Joint Supplement for Pet Segment by Type
Biscuits
Soft Treats
Chewable Tablets
Others
Hip and Joint Supplement for Pet Segment by Application
Dogs
Cats
Others
Hip and Joint Supplement for Pet Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hip and Joint Supplement for Pet market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Hip and Joint Supplement for Pet and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hip and Joint Supplement for Pet.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Hip and Joint Supplement for Pet manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Hip and Joint Supplement for Pet by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Hip and Joint Supplement for Pet in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Biscuits
- Soft Treats
- Chewable Tablets
- Others
Applications
- Dogs
- Cats
- Others
Companies covered
- Mars
- Nestle Purina
- EverRoot
- Milk-Bone
- Blue Buffalo
- VetIQ
- JPK Nutri
- maxxipaws
- Unicharm
- OSCAR Pet Foods
- Affinity Petcare
- MoonShine
- Yantai China Pet Foods
- GREENIES
- Wagg
- Petpal Tech
- DogKind
- Pet Treats
- Pet Chews
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Hip and Joint Supplement for Pet Market Size (2021-2032)
- 2.2.2 Global Hip and Joint Supplement for Pet Sales (2021-2032)
- 2.2.3 Global Hip and Joint Supplement for Pet Market Average Price (2021-2032)
- 2.3 Hip and Joint Supplement for Pet by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Biscuits
- 2.3.3 Soft Treats
- 2.3.4 Chewable Tablets
- 2.3.5 Others
- 2.4 Hip and Joint Supplement for Pet by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Dogs
- 2.4.3 Cats
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Hip and Joint Supplement for Pet Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Hip and Joint Supplement for Pet Sales (t) of Manufacturers (2021-2026)
- 3.3 Global Hip and Joint Supplement for Pet Revenue of Manufacturers (2021-2026)
- 3.4 Global Hip and Joint Supplement for Pet Average Price by Manufacturers (2021-2026)
- 3.5 Global Hip and Joint Supplement for Pet Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Hip and Joint Supplement for Pet, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Hip and Joint Supplement for Pet, Product Type & Application
- 3.8 Global Manufacturers of Hip and Joint Supplement for Pet, Established Date
- 3.9 Global Hip and Joint Supplement for Pet Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Mars
- 4.1.1 Mars Company Information
- 4.1.2 Mars Business Overview
- 4.1.3 Mars Hip and Joint Supplement for Pet Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Mars Hip and Joint Supplement for Pet Product Portfolio
- 4.1.5 Mars Recent Developments
- 4.2 Nestle Purina
- 4.2.1 Nestle Purina Company Information
- 4.2.2 Nestle Purina Business Overview
- 4.2.3 Nestle Purina Hip and Joint Supplement for Pet Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Nestle Purina Hip and Joint Supplement for Pet Product Portfolio
- 4.2.5 Nestle Purina Recent Developments
- 4.3 EverRoot
- 4.3.1 EverRoot Company Information
- 4.3.2 EverRoot Business Overview
- 4.3.3 EverRoot Hip and Joint Supplement for Pet Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 EverRoot Hip and Joint Supplement for Pet Product Portfolio
- 4.3.5 EverRoot Recent Developments
- 4.4 Milk-Bone
- 4.4.1 Milk-Bone Company Information
- 4.4.2 Milk-Bone Business Overview
- 4.4.3 Milk-Bone Hip and Joint Supplement for Pet Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Milk-Bone Hip and Joint Supplement for Pet Product Portfolio
- 4.4.5 Milk-Bone Recent Developments
- 4.5 Blue Buffalo
- 4.5.1 Blue Buffalo Company Information
- 4.5.2 Blue Buffalo Business Overview
- 4.5.3 Blue Buffalo Hip and Joint Supplement for Pet Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Blue Buffalo Hip and Joint Supplement for Pet Product Portfolio
- 4.5.5 Blue Buffalo Recent Developments
- 4.6 VetIQ
- 4.6.1 VetIQ Company Information
- 4.6.2 VetIQ Business Overview
- 4.6.3 VetIQ Hip and Joint Supplement for Pet Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 VetIQ Hip and Joint Supplement for Pet Product Portfolio
- 4.6.5 VetIQ Recent Developments
- 4.7 JPK Nutri
- 4.7.1 JPK Nutri Company Information
- 4.7.2 JPK Nutri Business Overview
- 4.7.3 JPK Nutri Hip and Joint Supplement for Pet Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 JPK Nutri Hip and Joint Supplement for Pet Product Portfolio
- 4.7.5 JPK Nutri Recent Developments
- 4.8 maxxipaws
- 4.8.1 maxxipaws Company Information
- 4.8.2 maxxipaws Business Overview
- 4.8.3 maxxipaws Hip and Joint Supplement for Pet Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 maxxipaws Hip and Joint Supplement for Pet Product Portfolio
- 4.8.5 maxxipaws Recent Developments
- 4.9 Unicharm
- 4.9.1 Unicharm Company Information
- 4.9.2 Unicharm Business Overview
- 4.9.3 Unicharm Hip and Joint Supplement for Pet Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Unicharm Hip and Joint Supplement for Pet Product Portfolio
- 4.9.5 Unicharm Recent Developments
- 4.10 OSCAR Pet Foods
- 4.10.1 OSCAR Pet Foods Company Information
- 4.10.2 OSCAR Pet Foods Business Overview
- 4.10.3 OSCAR Pet Foods Hip and Joint Supplement for Pet Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 OSCAR Pet Foods Hip and Joint Supplement for Pet Product Portfolio
- 4.10.5 OSCAR Pet Foods Recent Developments
- 4.11 Affinity Petcare
- 4.11.1 Affinity Petcare Company Information
- 4.11.2 Affinity Petcare Business Overview
- 4.11.3 Affinity Petcare Hip and Joint Supplement for Pet Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Affinity Petcare Hip and Joint Supplement for Pet Product Portfolio
- 4.11.5 Affinity Petcare Recent Developments
- 4.12 MoonShine
- 4.12.1 MoonShine Company Information
- 4.12.2 MoonShine Business Overview
- 4.12.3 MoonShine Hip and Joint Supplement for Pet Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 MoonShine Hip and Joint Supplement for Pet Product Portfolio
- 4.12.5 MoonShine Recent Developments
- 4.13 Yantai China Pet Foods
- 4.13.1 Yantai China Pet Foods Company Information
- 4.13.2 Yantai China Pet Foods Business Overview
- 4.13.3 Yantai China Pet Foods Hip and Joint Supplement for Pet Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Yantai China Pet Foods Hip and Joint Supplement for Pet Product Portfolio
- 4.13.5 Yantai China Pet Foods Recent Developments
- 4.14 GREENIES
- 4.14.1 GREENIES Company Information
- 4.14.2 GREENIES Business Overview
- 4.14.3 GREENIES Hip and Joint Supplement for Pet Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 GREENIES Hip and Joint Supplement for Pet Product Portfolio
- 4.14.5 GREENIES Recent Developments
- 4.15 Wagg
- 4.15.1 Wagg Company Information
- 4.15.2 Wagg Business Overview
- 4.15.3 Wagg Hip and Joint Supplement for Pet Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Wagg Hip and Joint Supplement for Pet Product Portfolio
- 4.15.5 Wagg Recent Developments
- 4.16 Petpal Tech
- 4.16.1 Petpal Tech Company Information
- 4.16.2 Petpal Tech Business Overview
- 4.16.3 Petpal Tech Hip and Joint Supplement for Pet Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 Petpal Tech Hip and Joint Supplement for Pet Product Portfolio
- 4.16.5 Petpal Tech Recent Developments
- 4.17 DogKind
- 4.17.1 DogKind Company Information
- 4.17.2 DogKind Business Overview
- 4.17.3 DogKind Hip and Joint Supplement for Pet Sales, Revenue and Gross Margin (2021-2026)
- 4.17.4 DogKind Hip and Joint Supplement for Pet Product Portfolio
- 4.17.5 DogKind Recent Developments
- 4.18 Pet Treats
- 4.18.1 Pet Treats Company Information
- 4.18.2 Pet Treats Business Overview
- 4.18.3 Pet Treats Hip and Joint Supplement for Pet Sales, Revenue and Gross Margin (2021-2026)
- 4.18.4 Pet Treats Hip and Joint Supplement for Pet Product Portfolio
- 4.18.5 Pet Treats Recent Developments
- 4.19 Pet Chews
- 4.19.1 Pet Chews Company Information
- 4.19.2 Pet Chews Business Overview
- 4.19.3 Pet Chews Hip and Joint Supplement for Pet Sales, Revenue and Gross Margin (2021-2026)
- 4.19.4 Pet Chews Hip and Joint Supplement for Pet Product Portfolio
- 4.19.5 Pet Chews Recent Developments
5 Global Hip and Joint Supplement for Pet Market Scenario by Region
- 5.1 Global Hip and Joint Supplement for Pet Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Hip and Joint Supplement for Pet Sales by Region: 2021-2032
- 5.2.1 Global Hip and Joint Supplement for Pet Sales by Region: 2021-2026
- 5.2.2 Global Hip and Joint Supplement for Pet Sales by Region: 2027-2032
- 5.3 Global Hip and Joint Supplement for Pet Revenue by Region: 2021-2032
- 5.3.1 Global Hip and Joint Supplement for Pet Revenue by Region: 2021-2026
- 5.3.2 Global Hip and Joint Supplement for Pet Revenue by Region: 2027-2032
- 5.4 North America Hip and Joint Supplement for Pet Market Facts & Figures by Country
- 5.4.1 North America Hip and Joint Supplement for Pet Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Hip and Joint Supplement for Pet Sales by Country (2021-2032)
- 5.4.3 North America Hip and Joint Supplement for Pet Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Hip and Joint Supplement for Pet Market Facts & Figures by Country
- 5.5.1 Europe Hip and Joint Supplement for Pet Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Hip and Joint Supplement for Pet Sales by Country (2021-2032)
- 5.5.3 Europe Hip and Joint Supplement for Pet Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Hip and Joint Supplement for Pet Market Facts & Figures by Country
- 5.6.1 Asia Pacific Hip and Joint Supplement for Pet Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Hip and Joint Supplement for Pet Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Hip and Joint Supplement for Pet Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Hip and Joint Supplement for Pet Market Facts & Figures by Country
- 5.7.1 South America Hip and Joint Supplement for Pet Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Hip and Joint Supplement for Pet Sales by Country (2021-2032)
- 5.7.3 South America Hip and Joint Supplement for Pet Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Hip and Joint Supplement for Pet Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Hip and Joint Supplement for Pet Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Hip and Joint Supplement for Pet Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Hip and Joint Supplement for Pet Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Hip and Joint Supplement for Pet Sales by Type (2021-2032)
- 6.1.1 Global Hip and Joint Supplement for Pet Sales by Type (2021-2032) & (t)
- 6.1.2 Global Hip and Joint Supplement for Pet Sales Market Share by Type (2021-2032)
- 6.2 Global Hip and Joint Supplement for Pet Revenue by Type (2021-2032)
- 6.2.1 Global Hip and Joint Supplement for Pet Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Hip and Joint Supplement for Pet Revenue Market Share by Type (2021-2032)
- 6.3 Global Hip and Joint Supplement for Pet Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Hip and Joint Supplement for Pet Sales by Application (2021-2032)
- 7.1.1 Global Hip and Joint Supplement for Pet Sales by Application (2021-2032) & (t)
- 7.1.2 Global Hip and Joint Supplement for Pet Sales Market Share by Application (2021-2032)
- 7.2 Global Hip and Joint Supplement for Pet Revenue by Application (2021-2032)
- 7.2.1 Global Hip and Joint Supplement for Pet Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Hip and Joint Supplement for Pet Revenue Market Share by Application (2021-2032)
- 7.3 Global Hip and Joint Supplement for Pet Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Hip and Joint Supplement for Pet Value Chain Analysis
- 8.1.1 Hip and Joint Supplement for Pet Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Hip and Joint Supplement for Pet Production Mode & Process
- 8.2 Hip and Joint Supplement for Pet Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Hip and Joint Supplement for Pet Distributors
- 8.2.3 Hip and Joint Supplement for Pet Customers
9 Global Hip and Joint Supplement for Pet Analyzing Market Dynamics
- 9.1 Hip and Joint Supplement for Pet Industry Trends
- 9.2 Hip and Joint Supplement for Pet Industry Drivers
- 9.3 Hip and Joint Supplement for Pet Industry Opportunities and Challenges
- 9.4 Hip and Joint Supplement for Pet Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst